| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,485 |
4,179 |
$453K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
642 |
578 |
$83K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
135 |
127 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
113 |
109 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
48 |
44 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
753 |
669 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
244 |
218 |
$2K |
| 80053 |
Comprehensive metabolic panel |
812 |
702 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
40 |
38 |
$611.90 |
| 71046 |
Radiologic examination, chest; 2 views |
145 |
128 |
$389.68 |
| 83735 |
|
166 |
146 |
$342.66 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
132 |
105 |
$334.20 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
42 |
41 |
$205.92 |
| 85027 |
|
172 |
147 |
$190.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
38 |
38 |
$179.73 |
| 84484 |
|
15 |
12 |
$43.45 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
44 |
36 |
$35.04 |
| 81001 |
|
44 |
40 |
$33.30 |
| 85610 |
|
31 |
24 |
$15.46 |
| A9270 |
Non-covered item or service |
63 |
43 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
122 |
84 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
12 |
$0.00 |